# Perceptive Xontogeny Venture Funds

Perceptive Xontogeny Venture Funds is a Venture Capital based in New York, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2017
- **Assets under management:** Undisclosed
- **Website:** perceptivexontogeny.com
- **LinkedIn:** https://www.linkedin.com/company/perceptive-advisors

## Regulatory record

- **Reports private funds:** No

## About

Perceptive Advisors established its Venture Capital strategy with the launch of Perceptive Xontogeny Venture Fund, LP in 2018 and closed Perceptive Xontogeny Venture Fund II, LP in 2021. The strategy manages over $700 million dedicated to financing early-stage life sciences companies, primarily seed and Series A, with select later-stage financings. It partners with founders and invests in differentiated technologies seeking significant therapeutic impact on serious disease or improvements in healthcare delivery, across biotechnology, medtech, healthtech, digital health and healthcare tools/services.

## Sectors

- Biotech
- Pharmaceuticals
- Life Sciences
- Therapeutics
- Healthcare

## Offices

- Boston, MA, United States
- Tiburon, CA, United States

## People

- Chris Garabedian — CEO, Perceptive Xontogeny Venture Funds
- Joe Edelman — Founder and CEO, Perceptive Advisors

## Questions

### Who runs investment decisions at Perceptive Xontogeny Venture Funds?

Chris Garabedian serves as CEO and leads investment decisions for the venture funds. He previously founded Xontogeny, a biotech accelerator, and has a background in life sciences entrepreneurship. The fund is part of Perceptive Advisors, founded by Joe Edelman, but Garabedian directs the venture-focused portfolio.

### Does Perceptive Xontogeny participate in fund commitments or only direct deals?

The firm focuses exclusively on direct venture capital investments, primarily leading or co-leading rounds in early-stage biotech companies. They do not commit to other funds. Their model involves hands-on portfolio company building.

### Which sectors does Perceptive Xontogeny explicitly focus on?

The fund invests exclusively in life sciences, with a heavy emphasis on therapeutics, including gene therapy, cell therapy, and precision medicine. They also invest in diagnostics and platforms. They avoid non-life sciences sectors like tech or energy.

## Related profiles

- [Tether Limited](https://altss.com/profile/tether-limited)

---

Last updated: 2026-08-11T15:07:41.444Z

Canonical page: https://altss.com/profile/perceptive-xontogeny-venture-funds

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology